Skip to Main Content

Podcast Archive

HelixTalk #160 - Dextromethorphan for Depression? Analyzing Data for Auvelity® in Major Depressive Disorder

Date posted: January 31, 2023, 6:00 am

In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepressant with a unique mechanism of action and interesting pharmacokinetic considerations.


HelixTalk #159 - A Breath of Fresh Air: Big Changes to the 2023 GOLD Guidelines for COPD

Date posted: January 10, 2023, 6:00 am

In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group classification system and the preferred initial therapies in patients with COPD.


HelixTalk #158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview

Date posted: December 21, 2022, 6:00 am

In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs.


HelixTalk #157 - Everything Will Be ao-K+: Potassium Formulations and Dosing for Hypokalemia

Date posted: November 29, 2022, 6:00 am

In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potassium chloride supplements and what dosage forms are available for potassium repletion.


HelixTalk #156 - There Is an App for That: Digital Health Advancements and More!

Date posted: November 8, 2022, 6:00 am

In this episode, we will define Digital Health, its categories and examples, describe how pharmacists are involved in DH practice, opportunities and limitations and future of DH. We will also discuss what implications DH has for educators, educational institutions, student pharmacists, pharmacists, and practice of pharmacy in general.


HelixTalk #155 - Oncology 911: Tumor Lysis Syndrome as an Oncologic Emergency

Date posted: October 18, 2022, 6:00 am

In this episode, we invite Dr. Amir Ali, PharmD, BCOP to discuss with us the pathophysiology, risk factors, prevention, and treatment clinical pearls of tumor lysis syndrome TLS).


HelixTalk #154 - What’s New With Paxlovid: Drug Interactions, Pharmacist Prescribing, “Paxlovid Mouth”, and a Brief Drug Review

Date posted: September 27, 2022, 6:00 am

In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists’ authority to prescribe, drug interactions, and rebound symptoms after Paxlovid therapy.


HelixTalk #153 - Buy One Get One Free: Learning All about the Dual Acting GIP and GLP-1 Receptor Agonist

Date posted: September 6, 2022, 6:00 am

In this episode, we will discuss mechanism, pharmacokinetics, efficacy, safety, and possible place in therapy for tirzepatide (Mounjaro), a new treatment for type 2 diabetes.


HelixTalk #152 - Strain-ger Things: Pneumococcal Vaccine Updates

Date posted: August 16, 2022, 6:00 am

In this episode, we will discuss the rationale behind the FDA approval of two new pneumococcal conjugate vaccines (PCV20 and PCV15), the characteristics of these vaccines, their place in therapy as recommended by the ACIP, and subsequent CDC immunization schedule changes.


HelixTalk #151 - Deep Dive into Diltiazem: Pharmaceutics, Medicinal Chemistry, the FDA Orange Book, and More!

Date posted: July 26, 2022, 6:00 am

In this episode, we “deep dive” into diltiazem, describing its most important drug facts, pharmacology and medicinal chemistry, pharmaceutics, AB compatibility, and important medication safety issues.